The World Health Organisation said on Friday it expected to begin small-scale use of two experimental Ebola vaccines in West Africa early next year and in the meantime transfusions of survivors' blood may offer the best hope of treatment. WHO is working with pharmaceutical companies and regulators to accelerate the use of a range of potential treatments to fight the disease, a senior WHO official said.